Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Boehringer Ingelheim
Johnson and Johnson

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,674,895

« Back to Dashboard

Summary for Patent: 5,674,895

Title: Dosage form comprising oxybutynin
Abstract:A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
Inventor(s): Guittard; George V. (Cupertino, CA), Jao; Francisco (San Jose, CA), Marks; Susan M. (San Jose, CA), Kidney; David J. (Sunnyvale, CA), Gumucio; Fernando (Santa Clara, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:08/445,849
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Device;

No matches for this query

International Patent Family for Patent: 5,674,895

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom9723081► Subscribe
France2734483► Subscribe
Spain2141044► Subscribe
Germany19681389► Subscribe
United Kingdom2318055► Subscribe
ItalyTO960427► Subscribe
Switzerland690955► Subscribe
Canada2510391► Subscribe
Canada2218714► Subscribe
Belgium1009462► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: